DNA X, Inc. (SONM) Free cash flow 2018–2024
DNA X, Inc. (SONM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.7MFY2024 · since FY2018: $3.1M → -$8.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$8.7M | -112.8% |
| FY2023 | -$4.1M | +66.9% |
| FY2022 | -$12.4M | +67.9% |
| FY2021 | -$38.5M | -264.4% |
| FY2020 | -$10.6M | +69.4% |
| FY2019 | -$34.5M | -1222.8% |
| FY2018 | $3.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice